Response Determination Criteria for ELISPOT: Toward a Standard that Can Be Applied Across Laboratories
Zoe Moodie(Fred Hutch Cancer Center), Cedrik M. Britten(Johannes Gutenberg University Mainz), Sylvia Janetzki(Yale University), Leah Price(Cwm Taf University Health Board)
Cited by 51
Related Papers
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
|The Lancet Infectious Diseases|2011|385
Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector
|The Journal of Infectious Diseases|2006|318
A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial
|Clinical and Vaccine Immunology|2006|236